This content is from: Features

Repurposed drugs and your IP strategy

Using examples of drugs and companies, Dr Andreas Persidis gives tips on how to establish a systematic drug repositioning programme

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial